New App for Prostate Ultrasound System Announced
By MedImaging International staff writers Posted on 04 Apr 2017 |
Image: The micro-ultrasound platform enables urologists to perform targeted biopsies using standard urological workflows (Photo courtesy of Exact Imaging).
A new micro-ultrasound/MRI fusion application for a micro-ultrasound prostate imaging and biopsy guidance system has been showcased.
The application allows urologists to import radiological reports from Magnetic Resonance Imaging (MRI) scans, or annotated MR images with MRI-identified lesions, co-aligned with the live real-time micro-ultrasound scan. The urologist can also use the MRI-identified lesions during the total biopsy procedure.
The FusionVu application was developed by Exact Imaging and runs on the company's ExactVu platform. According to Exact Imaging this provides the urologist with a total urological solution that can be upgraded, and scaled up. The system is based on standard urological workflows, and does not need any additional hardware or radiological software to run. FusionVu is intended for patients with exclusive anterior lesions, or those with previous negative biopsies.
Exact Imaging's ExactVu micro-ultrasound platform works at 29 MHz, and has received the European Union (CE Mark), US FDA 510(k) approval, and the Health Canada license. The system can be used for systematic biopsy protocols, and can visualize areas of interest in the prostate and target biopsies in those areas.
President and CEO of Exact Imaging, Randy AuCoin, said, "At least 70% of prostate cancer is located in the peripheral zone, which is exquisitely visualized and targetable with the 70 micron resolution of the ExactVu micro-ultrasound system. Our evidence-based PRI-MUS protocol is easily applied to help urologists identify and characterize regions and then to target those suspicious regions."
The application allows urologists to import radiological reports from Magnetic Resonance Imaging (MRI) scans, or annotated MR images with MRI-identified lesions, co-aligned with the live real-time micro-ultrasound scan. The urologist can also use the MRI-identified lesions during the total biopsy procedure.
The FusionVu application was developed by Exact Imaging and runs on the company's ExactVu platform. According to Exact Imaging this provides the urologist with a total urological solution that can be upgraded, and scaled up. The system is based on standard urological workflows, and does not need any additional hardware or radiological software to run. FusionVu is intended for patients with exclusive anterior lesions, or those with previous negative biopsies.
Exact Imaging's ExactVu micro-ultrasound platform works at 29 MHz, and has received the European Union (CE Mark), US FDA 510(k) approval, and the Health Canada license. The system can be used for systematic biopsy protocols, and can visualize areas of interest in the prostate and target biopsies in those areas.
President and CEO of Exact Imaging, Randy AuCoin, said, "At least 70% of prostate cancer is located in the peripheral zone, which is exquisitely visualized and targetable with the 70 micron resolution of the ExactVu micro-ultrasound system. Our evidence-based PRI-MUS protocol is easily applied to help urologists identify and characterize regions and then to target those suspicious regions."
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer